We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 51,807

21st Century Cures Advances to Senate; Health Bills Scheduled for House Floor; MedPAC Meetings This Week
  • Squire Patton Boggs
  • USA
  • December 5 2016

Last week the Senate amendment to H.R. 34, the Tsunami Warning, Education, and Research Act


New POS Code for Telehealth Distant Site Providers
  • Ober Kaler
  • USA
  • December 2 2016

A new Place of Services or POS code for Telehealth services (POS 02) will go into effect on January 1, 2017. The descriptor for the code, which is for


Governmental Updates You Need to Know About
  • Sedgwick LLP
  • USA
  • December 2 2016

In the past few weeks, the government issued alerts and guidance on two noteworthy topics involving data security issues: phishing and ransomware -


This Week in Washington - December 2, 2016
  • Hall Render Killian Heath & Lyman PC
  • USA
  • December 2 2016

On November 29, President-elect Donald Trump announced his choice to lead the top federal health care agencies. Trump nominated Rep. Tom Price, MD


OCR Provides Additional Clarification on Phishing Scam
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • December 2 2016

As we reported earlier this week, the U.S. Department of Health and Human Services (HHS) Office for Civil Rights described a phishing campaign that


EPA Signs Final RFS Requirements
  • Bergeson & Campbell PC
  • USA
  • December 2 2016

On November 23, 2016, EPA Administrator, GINA McCarthy, signed the final rule on the RFS volume standards for 2017 and biobased diesel standards for


Divide Deepens Over Whether Escobar Requires Specific Misrepresentations To State An Implied Certification Claim
  • Sidley Austin LLP
  • USA
  • December 2 2016

As we reported earlier, district courts have split on whether Escobar's so-called "two-part test" is the sole means of establishing implied


Ranbaxy and AstraZeneca Prevail in Nexium Pay-For-Delay Case
  • Knobbe Martens Olson & Bear LLP
  • USA
  • December 2 2016

On November 21, 2016, the U.S. Court of Appeals for the First Circuit upheld a 2014 jury verdict for AstraZeneca (AZ) and Ranbaxy regarding a 2012


Jury verdict in the US delivers $1 billion judgment against Depuy and their Pinnacle Ultamet metal-on-metal hip
  • Leigh Day
  • USA
  • December 2 2016

On Thursday 1 December 2016, a US jury found Johnson & Johnson’s DePuy Orthopaedics Inc. unit liable for more than $1.04 billion in respect of their


Gearing Up for Change: President-Elect Trump's Nominees to Head HHS and CMS, and their Views on the ACA, Medicare, and Medicaid
  • Hogan Lovells
  • USA
  • December 1 2016

On November 29, 2016, President-elect Trump announced Congressman Tom Price as his intended nominee for Secretary of Health and Human Services, and